Page 38 - மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covid latest: Lockdowns in some parts of the world; vaccine shortage in poor countries; India reports record 1 45 lakh cases

Covid latest: Lockdowns in some parts of the world; vaccine shortage in poor countries; India reports record 1 45 lakh cases
coastaldigest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from coastaldigest.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNew delhiUttar pradeshMadhya pradeshTamil naduHarsh vardhanTedros adhanom ghebreysusUnion health ministryUnion healthNational institute of healthDrug regulatory authority of pakistanWorld health organizationAssociated pressSerum instituteUnion health minister harsh vardhan

Pakistan approves third Chinese Covid vaccine despite low efficacy

Pakistan approves third Chinese Covid vaccine despite low efficacy
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Sinovac biotechDrug regulatory authority of pakistanCansino biologicals incDrug regulatory authorityEmergency use authorisationCansino biologicalsUnited kingdomGeo newsமருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான்கேன்சினோ உயிரியல் இன்க்மருந்து ஒழுங்குமுறை அதிகாரம்கேன்சினோ உயிரியல்ஒன்றுபட்டது கிஂக்டம்புவி செய்தி

U S Cases Hit Two-Week High; India in Crisis: Virus Update

U.S. Cases Hit Two-Week High; India in Crisis: Virus Update Bloomberg 1 hr ago Bloomberg News © Bloomberg A sign requiring protective face masks in Campus Martius in Detroit, Michigan, U.S., on Sunday, March 21, 2021. After seeing declines in Covid-19 case numbers and hospitalizations in January and February, Michigan s coronavirus curve is rocketing skyward yet again as restrictions have relaxed, the Detroit Free Press reports. (Bloomberg) Surging cases in the Midwest helped push the number of daily U.S. infections to their highest in more than two weeks as the nation’s vaccination push regains pace. A divided U.S. Supreme Court eased California’s curbs on at-home religious services.

South koreaUnited kingdomBuckingham palaceUttar pradeshUnited statesBruxelles capitaleCity ofSouth koreanAugsburger allgemeineWindsor castleTedros adhanom ghebreyesusRalph gonsalvesThorsten schuellerThierry bretonElon muskCharles michel

Authorisation of fifth vaccine allowed

Authorisation of fifth vaccine allowed Top Story April 9, 2021 KARACHI: The registration board of Drug Regulatory Authority of Pakistan (DRAP) has allowed another Chinese vaccine, CoronaVac, for COVID-19, officials said on Thursday adding that despite its low efficacy shown during the trials, the vaccine was allowed to counter the third wave of pandemic in Pakistan. “DRAP’s registration board in its 304th meeting on Thursday gave Emergency Use Authorization (EUA) to CoronaVac vaccine, developed by the Sinovac Life Sciences Company Ltd., based in Beijing, China,” an official of the Drug Regulatory Authority told The News on Thursday. This would be the fifth Covid-19 vaccine and the third Chinese vaccine to be allowed to be used in Pakistan as earlier, Pakistan had granted Emergency Use Authorization (EUA) to China’s two dose Sinopharm and single dose Convidecia vaccine developed by the Cansino Biologicals Inc. Oxford’s AstraZeneca’s Covishield and Russian Sputnik V v

Oxford astrazeneca covishieldAnhui zhifei longcom biopharmaceutical company ltdDrug regulatory authority of pakistanCansino biologicals incDrug regulatory authoritySinovac life sciences company ltdEmergency use authorizationCansino biologicalsTwo chineseMiddle easternமருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான்கேன்சினோ உயிரியல் இன்க்மருந்து ஒழுங்குமுறை அதிகாரம்அவசரம் பயன்பாடு அங்கீகாரம்கேன்சினோ உயிரியல்இரண்டு சீன

DRAP allows emergency authorisation to fifth Covid-19 vaccine

The image shows package of Chinese COVID-19 vaccine produced by Beijing-based Sinovac Life Sciences Company Ltd. KARACHI: The registration board of Drug Regulatory Authority of Pakistan (DRAP) has allowed another Chinese vaccine, CoronaVac, for COVID-19, officials said on Thursday adding that despite its low efficacy shown during the trials, the vaccine was allowed to counter the third wave of pandemic in Pakistan. “DRAP’s registration board in its 304th meeting on Thursday gave Emergency Use Authorization (EUA) to CoronaVac vaccine, developed by the Sinovac Life Sciences Company Ltd., based in Beijing, China, an official of the Drug Regulatory Authority told The News on Thursday. This would be the fifth Covid-19 vaccine and the third Chinese vaccine to be allowed to be used in Pakistan as earlier, Pakistan had granted Emergency Use Authorization (EUA) to China’s two dose Sinopharm and single dose Convidecia vaccine developed by the Cansino Biologicals Inc. Oxford s AstraZen

Oxford astrazeneca covishieldAnhui zhifei longcom biopharmaceutical company ltdDrug regulatory authority of pakistanCansino biologicals incDrug regulatory authoritySinovac life sciences company ltdEmergency use authorizationCansino biologicalsTwo chineseMiddle easternமருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான்கேன்சினோ உயிரியல் இன்க்மருந்து ஒழுங்குமுறை அதிகாரம்அவசரம் பயன்பாடு அங்கீகாரம்கேன்சினோ உயிரியல்இரண்டு சீன